Today in News History

On July 12, several notable moments in the history of News stand out. In 1849, William Osler, Canadian physician and author (died 1919) was born. In 1863, Albert Calmette, French physician, bacteriologist, and immunologist (died 1933) was born. In 1933, Victor Poor, American engineer, developed the Datapoint 2200 (died 2012) was born. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 1952, Voja Antonić, Serbian computer scientist and journalist, designed the Galaksija computer was born. In 1959, Karl J. Friston, English psychiatrist and neuroscientist was born. In 1966, Annabel Croft, English tennis player and sportscaster was born. In 1984, Natalie Martinez, American actress was born. In 2014, Alfred de Grazia, American political scientist and author (born 1919) passed away. In 2024, Bill Viola, American video and installation artist (born 1951) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

AI helps colonoscopies detect more lesions in high-risk patients: NTUH

Focus Taiwan

Focus Taiwan

·

July 6, 2026

·

center

Taipei, July 6 (CNA) A clinical trial in Taiwan has found that AI-assisted colonoscopies can help doctors detect more adenomas among people at high risk of colorectal cancer, potentially offering greater prevention of the disease.

Narrative Intelligence Brief

This article was published by Focus Taiwan, a source frequently categorized with a center bias based in Taiwan. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Focus Taiwan, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

6 sources

Left 50%

Center 17%

Right 33%


Medical Daily

center

· Jul 9, 2026

Patients Can Be Identified from Medical AI Training Data with Near-Perfect Accuracy, New Study Finds

A Nature study found medical AI training data can identify individual patients at near-perfect accuracy. Racial minorities and rare disease patients face the highest risk.

The Motley Fool

lean left

· Jul 4, 2026

Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Heartflow scales AI diagnostics while Iovance drives personalized cancer therapies, each faces unique financial and operational risks in 2026.

L.A. Times - Health

left

· Jul 8, 2026

Contributor: The crucial medical question that AI can't ever answer

AI can be very knowledgeable. Doctors can have excellent judgment. But ultimately the patient's own priorities often determine which treatment approach is best.

NaturalNews.com

right

· Jul 4, 2026

Some IBD Patients Produce Antibodies That Block Key Inflammation Regulator, Study Finds

(NaturalNews) Study Finds Autoantibodies Against IL-10 in Subset of IBD PatientsApproximately 3.5 percent of people with inflammatory bowel disease (IBD) produce ...

The Next Web

lean left

· Jun 30, 2026

Jon and Mindy Gray bet $55M on AI to catch cancer before it starts

A new institute at Penn’s Basser Center will use artificial intelligence and biomarkers to intercept hereditary cancers at their earliest stages, before they become disease. The idea behind the gift is unusual enough to need its own word. Most cancer philanthropy funds treatment, the long campaign that begins once a tumour has announced itself. Jon [] This story continues at The Next Web

Seeking Alpha

lean right

· Jun 24, 2026

argenx SE (ARGX) Discusses R&D Spotlight on Advancing FcRn Leadership in Autoimmune Myositis Transcript

argenx SE (ARGX) Discusses R&D Spotlight on Advancing FcRn Leadership in Autoimmune Myositis Transcript

Topics:

Health · 3
Business · 2
Technology · 1

Related coverage for "AI helps colonoscopies detect more lesions in high-risk patients: NTUH": Medical Daily — Patients Can Be Identified from Medical AI Training Data with Near-Perfect Accuracy, New Study Finds. The Motley Fool — Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?. L.A. Times - Health — Contributor: The crucial medical question that AI can't ever answer. NaturalNews.com — Some IBD Patients Produce Antibodies That Block Key Inflammation Regulator, Study Finds. The Next Web — Jon and Mindy Gray bet $55M on AI to catch cancer before it starts. Seeking Alpha — argenx SE (ARGX) Discusses R&D Spotlight on Advancing FcRn Leadership in Autoimmune Myositis Transcript